An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn’s Disease

INTRODUCTION: Real-world treatment persistence to ustekinumab for Crohn’s disease (CD) was studied using Australian Pharmaceutical Benefits Scheme (PBS) data. Demographic and treatment pattern characteristics were also investigated. METHODS: Our retrospective cohort analysis included PBS 10% sample...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biologics
Autori principali: Chien, Tzu Hsiang, Puig, Andrea, Khuong, Thang, Kouhkamari, Mahsa H, Che, Samuel, Huang, Tom Hsun-Wei
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2021
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215905/
https://ncbi.nlm.nih.gov/pubmed/34163137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S310076
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi